News

Filter

Current filters:

Nelarabine

GSK's Atriance approved by EC

03-09-2007

UK drug major GlaxoSmithKline's Atriance (nelarabine solution for infusion) has received approval from…

ArranonGlaxoSmithKlineGSKNelarabine

GSK to launch Atriance in Europe

16-07-2007

UK-based drug major GlaxoSmithKline is to launch its drug Atriance (nelarabine), approved for the treatment…

ArranonGlaxoSmithKlineGSKNelarabine

GSK's Tykerb under EMEA review

16-10-2006

UK-based drug major GlaxoSmithKline says that it has submitted a Marketing Authorization Application…

ArranoncapecitabineGlaxoSmithKlineGSKHycamtinLapatinibNelarabineRocheTopotecan HydrochlorideTykerbXeloda

GSK files Atriance for blood cancers with EC

10-07-2006

UK-based drug major GlaxoSmithKline says that it has submitted a Marketing Authorization Application…

ArranonGlaxoSmithKlineGSKNelarabine

JPMA issues guidelines for research tool patent

30-01-2006

The Japan Pharmaceutical Manufacturer's Association has announced guidelines for licensing research tool…

ArranonBuphenylDrug DiscoveryGlaxoSmithKlineGSKNelarabineNovartisOncasparOxcarbazepinePegaspargaseSodium Phenylbutyrate TabletsTrileptal

Promising new data for GSK's nelarabine

22-12-2003

Results presented at the 45th Annual Meeting of the American Society ofHematology in San Diego, California,…

ArranonGlaxoSmithKlineGSKNelarabine

COMPANY SPOTLIGHT

Menarini

Back to top